| __timestamp | Insmed Incorporated | Lantheus Holdings, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 31073000 | 72429000 |
| Thursday, January 1, 2015 | 43216000 | 78634000 |
| Friday, January 1, 2016 | 50679000 | 75374000 |
| Sunday, January 1, 2017 | 79171000 | 92157000 |
| Monday, January 1, 2018 | 168218000 | 93326000 |
| Tuesday, January 1, 2019 | 210796000 | 103132000 |
| Wednesday, January 1, 2020 | 203613000 | 110171000 |
| Friday, January 1, 2021 | 234273000 | 218817000 |
| Saturday, January 1, 2022 | 265784000 | 233827000 |
| Sunday, January 1, 2023 | 344501000 | 267194000 |
Unlocking the unknown
In the competitive landscape of the pharmaceutical industry, understanding the financial strategies of key players is crucial. Over the past decade, Insmed Incorporated and Lantheus Holdings, Inc. have shown distinct trends in their Selling, General, and Administrative (SG&A) expenses.
From 2014 to 2023, Insmed's SG&A expenses surged by over 1,000%, reflecting a strategic investment in growth and market expansion. In contrast, Lantheus exhibited a more moderate increase of approximately 270%, indicating a steady yet cautious approach. Notably, in 2023, Insmed's expenses peaked at 344 million, surpassing Lantheus by nearly 29%.
These trends highlight differing corporate strategies: Insmed's aggressive expansion versus Lantheus's balanced growth. As the industry evolves, monitoring these financial maneuvers offers valuable insights into each company's market positioning and future potential.
Regeneron Pharmaceuticals, Inc. vs Lantheus Holdings, Inc.: SG&A Expense Trends
Insmed Incorporated vs Halozyme Therapeutics, Inc.: SG&A Expense Trends
Research and Development Investment: Insmed Incorporated vs Lantheus Holdings, Inc.
SG&A Efficiency Analysis: Comparing Insmed Incorporated and Pharming Group N.V.
Insmed Incorporated and Opthea Limited: SG&A Spending Patterns Compared
Insmed Incorporated and Ligand Pharmaceuticals Incorporated: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Blueprint Medicines Corporation and Lantheus Holdings, Inc.
Lantheus Holdings, Inc. or Ultragenyx Pharmaceutical Inc.: Who Manages SG&A Costs Better?
Lantheus Holdings, Inc. or Xenon Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Lantheus Holdings, Inc. and Merus N.V.
Cost Management Insights: SG&A Expenses for Lantheus Holdings, Inc. and Galapagos NV
Lantheus Holdings, Inc. and Travere Therapeutics, Inc.: SG&A Spending Patterns Compared